The Animal Model Market is witnessing steady momentum driven by increasing investments in pharmaceutical research and biotechnology sectors. Innovations in genetic engineering and rising demand for preclinical testing have heightened the market scope and business growth prospects, establishing a robust foundation for continued expansion.
Market Size and Overview
The Global Animal Model Market size is estimated to be valued at USD 1,577.30 million in 2025 and is expected to reach USD 2,394.30 million by 2032, exhibiting a compound annual growth rate (CAGR) of 6.0% from 2025 to 2032. Animal Model Market Growth is propelled by escalating requirements for animal models in drug development, toxicity testing, and personalized medicine research. Evolving market dynamics reflect growing market revenue and expanding market segments across pharmaceutical, academic, and biotechnological research sectors.
Market Drivers
- Rising Demand for Preclinical and Toxicology Studies: The key market driver continues to be the increased reliance on animal models for accurate preclinical testing and toxicology studies. For instance, in 2024, the U.S. Food and Drug Administration (FDA) reported a 12% increase in preclinical testing submissions, underscoring how stringent regulatory requirements are propelling market growth. Pharmaceutical companies are leveraging transgenic animals to boost drug efficacy evaluation, accelerating innovation while capturing new market opportunities. This demand effectively enhances market share for companies providing advanced animal models.
PEST Analysis
- Political: The implementation of stricter animal welfare regulations by governments worldwide, such as the amendments to the EU Directive 2010/63/EU in early 2025, has prompted market companies to innovate humane and alternative animal models. These political developments impact market restraints as firms invest in compliance while identifying new market growth strategies.
- Economic: Economic recovery in 2024 post-global disruptions has resulted in increased research funding by both public and private sectors, expanding industry size and market revenue especially in North America and Asia-Pacific regions. Enhanced funding facilitates the adoption of sophisticated animal models and broadens the market scope.
- Social: Growing societal concerns about ethical animal testing have stimulated demand for refined and minimalistic animal models, corroborating market trends toward 3Rs (Replacement, Reduction, and Refinement) approach in animal research. Awareness campaigns in 2025 have helped mitigate market challenges related to opposition groups, fostering more balanced industry growth.
- Technological: Advancements in CRISPR and genome editing technologies in 2024-2025 have transformed the animal model market dynamics, enabling precise gene modifications and development of disease-specific models. These innovations enhance market insights and opportunities by improving the reliability and efficiency of animal testing.
Promotion and Marketing Initiative
In 2025, a prominent animal model provider launched a targeted digital campaign focusing on personalized medicine research collaborations, which increased their global client base by 18%. This strategic marketing initiative utilized case studies and webinars, showcasing novel animal models tailored to oncology research. Such promotion has positively impacted market revenue and highlighted how innovative marketing strategies directly influence business growth in the animal model market.
Key Players
- Charles River Laboratories International
- Envigo (a part of Covance)
- Taconic Biosciences
- The Jackson Laboratory
- Crown Bioscience
- BioIVT
- GenOway
- Cyagen Biosciences
- SAGE Labs
- WuXi AppTec
- Horizon Discovery
- Biomodels
- Envigo RMS
- Vivo Bio Tech
- Oriental Yeast Co.
- LiStarFish
- Biocytogen
- LAB-ON-GENE
- InVivos
- Transposagen
Recent strategies in 2024-2025 include:
- Charles River Laboratories substantially expanded its GMP-compliant animal breeding facilities leading to a 15% increase in market share.
- Taconic Biosciences launched novel immunodeficient mouse models targeting oncology, enhancing their market revenue with multi-million-dollar contract wins in early 2025.
- The Jackson Laboratory formed strategic partnerships with pharmaceutical firms for precision oncology models, significantly contributing to overall industry size and reinforcing their market position.
These efforts demonstrate a clear understanding of market growth strategies and reflect how market players adapt to evolving market analysis and opportunities.
FAQs
1. Who are the dominant players in the Animal Model Market?
The dominant players include Charles River Laboratories International, Taconic Biosciences, The Jackson Laboratory, and Envigo, who have leveraged expansions, product innovations, and strategic partnerships to strengthen their market presence.
2. What will be the size of the Animal Model Market in the coming years?
The market is forecasted to grow from USD 1,577.30 million in 2025 to USD 2,394.30 million by 2032, demonstrating a CAGR of 6.0%, driven by increased demand for preclinical testing and technological advancements.
3. Which end-user industry has the largest growth opportunity?
The pharmaceutical sector, particularly oncology and personalized medicine research, presents the largest growth opportunity due to intensified R&D activities and regulatory pressures worldwide.
4. How will market development trends evolve over the next five years?
Market trends will likely focus on genetically engineered models, alternative testing methods reducing animal use, and expansions in emerging economies, reflecting rising market revenue and diversified market segments.
5. What is the nature of the competitive landscape and challenges in the Animal Model Market?
The landscape is highly competitive with emphasis on technological innovation and regulatory compliance; challenges include ethical concerns and market restraints from strict animal welfare regulations but also offer opportunities for development of alternative models.
6. What go-to-market strategies are commonly adopted in the Animal Model Market?
Common strategies include digital marketing campaigns targeting precision medicine research, strategic partnerships, facility expansions, and focused product launches aligned with market growth strategies, leading to increased market share and business growth.
Get This Report in Japanese Language: 動物モデル市場
Get This Report in Korean Language: 동물 모델 시장
Read More Articles Related to this Industry- Key Parameters Measured by Blood Gas Analyzers and Their Clinical Significance
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comments
0 comment